首页 > 最新文献

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk最新文献

英文 中文
[Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome and Catastrophic Antiphospholipid Syndrome]. [非典型溶血性尿毒症综合征和灾难性抗磷脂综合征患者补体系统异常]。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn769
K A Demyanova, N L Kozlovskaya, L A Bobrova, L V Kozlov, S S Andina, V A Yurova, A M Kuchieva, S V Roshchupkina, E M Shilov

Background: The role of the alternative complement pathway (AP) abnormalities in the pathogenesis of aHUS is well studied. Clinical and morphological manifestations of atypical HUS and catastrophic APS are often similar. However, studies on the state of AP in patients with CAPS are virtually absent.

Aims: The aim of our study was to assess the state of AP in patients with CAPS and aHUS. Patients and methods: The study enrolled 67 patients (pts) with a diagnosis of CAPS (28 pts) and aHUS (39 pts). Studies of the complement system are made of 10 pts with CAPS and 20 aHUS. Factor H, I, B, D content, functional activity of factor H, and complement components C3, C4 was determined in serum by ELISA kit.

Results: Patients with CAPS and aHUS showed similar changes in complement biomarkers. The factor H level in the serum was significantly higher than the standard value. However, the specific activity of factor H reduced, mean rate 59% for aHUS and 26% for CAPS. The median value of factor D was twice higher than the normal range in both groups, indicating the activation of the AP.

Conclusions: There are indications of an AP activation not only in pts with aHUS but in CAPS pts too. We suppose that the activity of factor H is a more sensitive indicator of complement system changes than factor H level. Patients with CAPS and aHUS have similar clinical and laboratory characteristics. However, CAPS is more severe, with the involvement of a larger number of vascular beds. Perhaps this is due to the double damaging effects on the endothelium ― of antiphospholipid antibodies (aPL) and activated complement. So we hypothesize that CAPS can be called aPL-mediated TMA in pts with a complement system defect.

背景:替代性补体通路(AP)异常在aHUS发病机制中的作用已经得到了很好的研究。非典型溶血性尿毒综合征和灾难性APS的临床和形态学表现往往相似。然而,关于CAPS患者AP状态的研究几乎缺失。目的:我们研究的目的是评估CAPS和aHUS患者的AP状态。患者和方法:该研究纳入了67例诊断为CAPS(28例)和aHUS(39例)的患者。补体系统的研究由10名CAPS患者和20名aHUS患者组成。采用ELISA试剂盒检测血清中因子H、I、B、D含量、因子H功能活性及补体成分C3、C4的含量。结果:CAPS和aHUS患者的补体生物标志物变化相似。血清中H因子水平明显高于标准值。然而,H因子的比活性降低,aHUS的平均率为59%,CAPS的平均率为26%。在两组中,因子D的中位数都是正常范围的两倍,表明AP激活。结论:不仅在aHUS患者中,在CAPS患者中也有AP激活的迹象。我们认为因子H的活性是补体系统变化的一个比因子H水平更敏感的指标。CAPS和aHUS患者具有相似的临床和实验室特征。然而,CAPS更为严重,涉及更多的血管床。这可能是由于抗磷脂抗体(aPL)和活化补体对内皮细胞的双重破坏作用。因此,我们假设在补体系统缺陷的患者中,CAPS可以称为apl介导的TMA。
{"title":"[Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome and Catastrophic Antiphospholipid Syndrome].","authors":"K A Demyanova,&nbsp;N L Kozlovskaya,&nbsp;L A Bobrova,&nbsp;L V Kozlov,&nbsp;S S Andina,&nbsp;V A Yurova,&nbsp;A M Kuchieva,&nbsp;S V Roshchupkina,&nbsp;E M Shilov","doi":"10.15690/vramn769","DOIUrl":"https://doi.org/10.15690/vramn769","url":null,"abstract":"<p><strong>Background: </strong>The role of the alternative complement pathway (AP) abnormalities in the pathogenesis of aHUS is well studied. Clinical and morphological manifestations of atypical HUS and catastrophic APS are often similar. However, studies on the state of AP in patients with CAPS are virtually absent.</p><p><strong>Aims: </strong>The aim of our study was to assess the state of AP in patients with CAPS and aHUS. Patients and methods: The study enrolled 67 patients (pts) with a diagnosis of CAPS (28 pts) and aHUS (39 pts). Studies of the complement system are made of 10 pts with CAPS and 20 aHUS. Factor H, I, B, D content, functional activity of factor H, and complement components C3, C4 was determined in serum by ELISA kit.</p><p><strong>Results: </strong>Patients with CAPS and aHUS showed similar changes in complement biomarkers. The factor H level in the serum was significantly higher than the standard value. However, the specific activity of factor H reduced, mean rate 59% for aHUS and 26% for CAPS. The median value of factor D was twice higher than the normal range in both groups, indicating the activation of the AP.</p><p><strong>Conclusions: </strong>There are indications of an AP activation not only in pts with aHUS but in CAPS pts too. We suppose that the activity of factor H is a more sensitive indicator of complement system changes than factor H level. Patients with CAPS and aHUS have similar clinical and laboratory characteristics. However, CAPS is more severe, with the involvement of a larger number of vascular beds. Perhaps this is due to the double damaging effects on the endothelium ― of antiphospholipid antibodies (aPL) and activated complement. So we hypothesize that CAPS can be called aPL-mediated TMA in pts with a complement system defect.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"42-52"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
[The Primary Metatarsalgia: Pathogenesis, Biomechanics and Surgical Treatment]. 原发性跖骨痛:发病机制、生物力学和外科治疗。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn756
D S Bobrov, L J Slinjakov, N V Rigin

This paper presents a comprehensive review on the current concept of the diagnosis and treatment of central metatarsalgia on the basis of medical literature analyses. Metatarsalgia is the term for pain in the forefoot. This is a set of symptoms corresponding to a wide range of diseases. Central metatarsalgia is a kind of metatarsalgia which arises from structural-functional changes that lead to excessive pressure in the area of metatarsal heads. The data analysis demonstrated that presently various types of osteotomies of metatarsal bones are the main surgical treatment options with the chance of complication ranging from 6 to 50%. Weil-osteotomy is known to be the most popular type of osteotomy for treatment of central metatarsalgia. The most common complication of Weil-osteotomy is floating toe, the one that doesn’t contact with the supporting surface. In case Weil-osteotomy and intraphalangeal arthrodesis with trans acticular fixation are both performed, the complication of floating toe increases up to 50%. When Weil osteotomy, plantar plate repair, extensor digitorum longum tendon lengthening and triple Weil-osteotomy are performed simultaneously, the complication rate is 15% approximately which is much lower. Using combined osteotomy techniques as well as taking into account structural-functional pathologic changes of the forefoot and ligaments repair of metatarsalphalangeal joint will ensure the most successful development of surgical treatment techniques for central metatarsalgia.

本文在医学文献分析的基础上,对目前中枢性跖骨痛的诊断和治疗概念进行了全面的综述。跖痛是指前脚疼痛。这是一组与各种疾病相对应的症状。中枢性跖骨痛是由于结构功能改变导致跖骨头区压力过大而引起的一种跖骨痛。数据分析表明,目前各种类型的跖骨截骨术是主要的手术治疗选择,并发症发生率在6%至50%之间。weil -截骨术是治疗中枢性跖骨痛最常用的截骨术。weil -截骨术最常见的并发症是浮趾,即不与支撑面接触的趾。如果同时行weil -截骨术和经关节固定的指关节内融合术,浮趾并发症增加到50%。同时行Weil截骨术、足底钢板修复术、指伸肌腱延长术和三联Weil截骨术时,并发症发生率约为15%,大大降低。采用联合截骨技术,并考虑前足的结构功能病变和跖趾关节的韧带修复,将确保中枢性跖痛手术治疗技术的最成功发展。
{"title":"[The Primary Metatarsalgia: Pathogenesis, Biomechanics and Surgical Treatment].","authors":"D S Bobrov,&nbsp;L J Slinjakov,&nbsp;N V Rigin","doi":"10.15690/vramn756","DOIUrl":"https://doi.org/10.15690/vramn756","url":null,"abstract":"<p><p>This paper presents a comprehensive review on the current concept of the diagnosis and treatment of central metatarsalgia on the basis of medical literature analyses. Metatarsalgia is the term for pain in the forefoot. This is a set of symptoms corresponding to a wide range of diseases. Central metatarsalgia is a kind of metatarsalgia which arises from structural-functional changes that lead to excessive pressure in the area of metatarsal heads. The data analysis demonstrated that presently various types of osteotomies of metatarsal bones are the main surgical treatment options with the chance of complication ranging from 6 to 50%. Weil-osteotomy is known to be the most popular type of osteotomy for treatment of central metatarsalgia. The most common complication of Weil-osteotomy is floating toe, the one that doesn’t contact with the supporting surface. In case Weil-osteotomy and intraphalangeal arthrodesis with trans acticular fixation are both performed, the complication of floating toe increases up to 50%. When Weil osteotomy, plantar plate repair, extensor digitorum longum tendon lengthening and triple Weil-osteotomy are performed simultaneously, the complication rate is 15% approximately which is much lower. Using combined osteotomy techniques as well as taking into account structural-functional pathologic changes of the forefoot and ligaments repair of metatarsalphalangeal joint will ensure the most successful development of surgical treatment techniques for central metatarsalgia.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"53-8"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Peculiarities of Allergy Diagnosis in Children]. [儿童过敏诊断的特点]。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn799
L S Namazova-Barahona, M A Snovskaya, I L Mitushin, O V Kozhevnikova, A S Batyrova

Allergic disease is a serious problem in practical healthcare. Over the last 40 years there has been exponential growth in the prevalence. According to the world health organization information, allergic diseases are at the 2nd place in prevalence the children, behind the viral infections. Their frequency and severity are increasing. In this regard, the relevance of timely and skilled diagnostic allergopathology is most important. In this study the current state of the question of allergy diagnostics is considered, the international experience is summarized and the approach to the allergy diagnosis based on use of step-by-step identification of a causal and significant factor of allergic reactions is offered. On the basis of the analysis of relevance and the importance for patients of one or the other allergens (taking into account a source of allergens and age of patients) use of a step-by-step allergy diagnostics algorithm is offered. The first step is definition of clinical implications of an allergy. It means direct contact of the phisition with the patient, clarification of its complaints, clinical symptoms, medical history disease. The second step is the confirmation of IgE-dependent mechanism. It involves the using of screening tests that are selected depending on the clinical symptoms and seasonality manifestations (the screening module). The third step is to identify the source of the allergens that are most meaningful for the patient with using test panels (modules). The panels include the most common and clinically relevant triggers of allergic reactions. The fourth step is the search for an individual significant allergens, which were not included in the diagnostic modules. On the fifth step, we plan to conduct component-divided diagnostics and detect the antibodies to unique components of significant allergens. The developed diagnostics algorithm, corresponds to needs of both the adult, and children’s population and provides the personalized approach to the patients.

变态反应性疾病是实际医疗保健中的一个严重问题。在过去的40年里,发病率呈指数级增长。根据世界卫生组织的资料,过敏性疾病在儿童患病率中排名第二,仅次于病毒感染。它们发生的频率和严重程度都在增加。在这方面,及时和熟练的诊断过敏症病理是最重要的。在本研究中,考虑了过敏诊断问题的现状,总结了国际经验,并提供了基于逐步识别过敏反应的因果和重要因素的过敏诊断方法。在分析一种或另一种过敏原对患者的相关性和重要性的基础上(考虑到过敏原的来源和患者的年龄),提供了一种逐步过敏诊断算法的使用。第一步是定义过敏的临床意义。指与病人直接接触,澄清病人的主诉、临床症状、病史和疾病。第二步是ige依赖机制的确认。它涉及使用根据临床症状和季节性表现选择的筛选试验(筛选模块)。第三步是通过使用测试面板(模块)来确定对患者最有意义的过敏原来源。这些小组包括最常见和临床相关的过敏反应触发因素。第四步是寻找个体重要的过敏原,这些过敏原未包括在诊断模块中。第五步,我们计划进行成分划分诊断,检测针对重要过敏原的独特成分的抗体。开发的诊断算法,符合成人和儿童人群的需求,并为患者提供个性化的方法。
{"title":"[Peculiarities of Allergy Diagnosis in Children].","authors":"L S Namazova-Barahona,&nbsp;M A Snovskaya,&nbsp;I L Mitushin,&nbsp;O V Kozhevnikova,&nbsp;A S Batyrova","doi":"10.15690/vramn799","DOIUrl":"https://doi.org/10.15690/vramn799","url":null,"abstract":"<p><p>Allergic disease is a serious problem in practical healthcare. Over the last 40 years there has been exponential growth in the prevalence. According to the world health organization information, allergic diseases are at the 2nd place in prevalence the children, behind the viral infections. Their frequency and severity are increasing. In this regard, the relevance of timely and skilled diagnostic allergopathology is most important. In this study the current state of the question of allergy diagnostics is considered, the international experience is summarized and the approach to the allergy diagnosis based on use of step-by-step identification of a causal and significant factor of allergic reactions is offered. On the basis of the analysis of relevance and the importance for patients of one or the other allergens (taking into account a source of allergens and age of patients) use of a step-by-step allergy diagnostics algorithm is offered. The first step is definition of clinical implications of an allergy. It means direct contact of the phisition with the patient, clarification of its complaints, clinical symptoms, medical history disease. The second step is the confirmation of IgE-dependent mechanism. It involves the using of screening tests that are selected depending on the clinical symptoms and seasonality manifestations (the screening module). The third step is to identify the source of the allergens that are most meaningful for the patient with using test panels (modules). The panels include the most common and clinically relevant triggers of allergic reactions. The fourth step is the search for an individual significant allergens, which were not included in the diagnostic modules. On the fifth step, we plan to conduct component-divided diagnostics and detect the antibodies to unique components of significant allergens. The developed diagnostics algorithm, corresponds to needs of both the adult, and children’s population and provides the personalized approach to the patients.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"33-41"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
[Morphological Features of Mesenhymal Stroma Cells of Chorionic Villi]. 绒毛间充质间质细胞的形态学特征。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn767
N V Nizyaeva, T V Sukhacheva, G V Kulikova, M N Nagovitsyna, N E Kan, O R Baev, S V Pavlovich, R A Serov, A I Shchegolev, R A Poltavtseva

Background: Nowadays autologous mesenchymal placental stromal cells (MSCs) may use to treat for various diseases both of the mother and the child. Stroma of the placenta villi is appropriated origin for cell culture isolation.

Aim: of the study was to evaluate the possibility for selection and use of placental tissue for mesenchymal stromal cells. Materials and methods: The present study was based on 45 placental samples of women aged 27−38 yy. who underwent surgical delivery at 36−40 weeks of gestation. 30 of these women have been enrolled in the basic group including children with congenital abnormalities (CA). The comparison group consisted of 15 patients with physiological pregnancy. We performed histological examination (with hematoxylin and eosin staining), immunohistochemical examination (with use monoclonal antibodies CD90 (1:25; Abcam, UK), СD105 (1:500; Abcam, UK), CD44 (1:25; Dako), СD73 (1:200, Abcam, UK), and electron microscopy (by microscope Philips/FEI Corporation, Eindhoven, Holland). Eclipse 80i microscope (Nikon Corporation, Japan) was used to examine the immunohistochemical reactions as a brown staining. The evaluation of the intensity of reaction was conducted by NIS-Elements Advanced Research 3.2 program (Czech Republic). Student’s t-test and analysis of variance were used to compare the mean values. Differences were considered statistically significant at p<0.05.

Results: Interstitial cells of the stroma of the villi with CA had fibroblastic differentiation as revealed degenerative changes of the cells. The histologic examination with hematoxylin and eosin staining revealed significant fibrosis of the stroma of the placenta villi in CA group (p<0,01). Immunohistochemical study of stem and intermediate chorionic villi revealed no significant differences in staining of CD44+, СD90+, СD73+, and CD105+ cells if compared to the control group (p>0.05). Although CD105 expression was significantly lower in the CA group (0.058±0.0049) than in the control group (0.088±0.0039) (p<0.05). However, electron microscopy detected the villi interstitial stromal cells with fibroblastic differentiation in CA group.

Conclusions: Thus, it is necessary to exclude placenta with obstetrical history, somatic, and congenital pathology of the mother and the child when selecting the placental cell culture. Moreover, choosing a sample the morphological structure of the placenta should be taken into consideration. However, congenital malformations of the fetus, pathology of the mother cultivate mesenchymal stromal cells of placentas is inappropriate and should be taken advantage of the donor cells.

背景:目前自体胎盘间充质细胞(MSCs)可用于治疗母亲和孩子的各种疾病。胎盘绒毛间质是细胞培养分离的合适来源。目的:探讨胎盘组织作为间充质间质细胞的选择和应用的可能性。材料和方法:本研究基于45例27 ~ 38岁女性胎盘样本。在妊娠36 ~ 40周接受手术分娩。其中30名妇女被纳入基本组,包括患有先天性异常的儿童。对照组为生理妊娠患者15例。我们进行了组织学检查(苏木精和伊红染色),免疫组织化学检查(使用单克隆抗体CD90 (1:25;Abcam,英国),СD105 (1:500;Abcam, UK), CD44 (1:25;Dako), СD73 (1:20 00, Abcam,英国)和电子显微镜(由显微镜飞利浦/FEI公司,埃因霍温,荷兰)。使用Eclipse 80i显微镜(Nikon Corporation, Japan)检测免疫组织化学反应,采用棕色染色。反应强度评价采用NIS-Elements Advanced Research 3.2程序(捷克共和国)进行。采用学生t检验和方差分析比较平均值。结果认为差异具有统计学意义:CA绒毛间质间质细胞呈成纤维细胞分化,显示细胞退行性改变。苏木精染色和伊红染色组织学检查显示CA组胎盘绒毛间质明显纤维化(p0.05)。虽然CD105在CA组的表达量(0.058±0.0049)明显低于对照组(0.088±0.0039)(p结论:因此,在选择胎盘细胞培养物时,有必要排除有产科史、母婴躯体和先天性病理的胎盘。此外,选择胎盘的形态结构样本也应考虑在内。然而,先天畸形的胎儿,病理母体培养胎盘间充质间质细胞是不合适的,应利用供体细胞。
{"title":"[Morphological Features of Mesenhymal Stroma Cells of Chorionic Villi].","authors":"N V Nizyaeva,&nbsp;T V Sukhacheva,&nbsp;G V Kulikova,&nbsp;M N Nagovitsyna,&nbsp;N E Kan,&nbsp;O R Baev,&nbsp;S V Pavlovich,&nbsp;R A Serov,&nbsp;A I Shchegolev,&nbsp;R A Poltavtseva","doi":"10.15690/vramn767","DOIUrl":"https://doi.org/10.15690/vramn767","url":null,"abstract":"<p><strong>Background: </strong>Nowadays autologous mesenchymal placental stromal cells (MSCs) may use to treat for various diseases both of the mother and the child. Stroma of the placenta villi is appropriated origin for cell culture isolation.</p><p><strong>Aim: </strong>of the study was to evaluate the possibility for selection and use of placental tissue for mesenchymal stromal cells. Materials and methods: The present study was based on 45 placental samples of women aged 27−38 yy. who underwent surgical delivery at 36−40 weeks of gestation. 30 of these women have been enrolled in the basic group including children with congenital abnormalities (CA). The comparison group consisted of 15 patients with physiological pregnancy. We performed histological examination (with hematoxylin and eosin staining), immunohistochemical examination (with use monoclonal antibodies CD90 (1:25; Abcam, UK), СD105 (1:500; Abcam, UK), CD44 (1:25; Dako), СD73 (1:200, Abcam, UK), and electron microscopy (by microscope Philips/FEI Corporation, Eindhoven, Holland). Eclipse 80i microscope (Nikon Corporation, Japan) was used to examine the immunohistochemical reactions as a brown staining. The evaluation of the intensity of reaction was conducted by NIS-Elements Advanced Research 3.2 program (Czech Republic). Student’s t-test and analysis of variance were used to compare the mean values. Differences were considered statistically significant at p<0.05.</p><p><strong>Results: </strong>Interstitial cells of the stroma of the villi with CA had fibroblastic differentiation as revealed degenerative changes of the cells. The histologic examination with hematoxylin and eosin staining revealed significant fibrosis of the stroma of the placenta villi in CA group (p<0,01). Immunohistochemical study of stem and intermediate chorionic villi revealed no significant differences in staining of CD44+, СD90+, СD73+, and CD105+ cells if compared to the control group (p>0.05). Although CD105 expression was significantly lower in the CA group (0.058±0.0049) than in the control group (0.088±0.0039) (p<0.05). However, electron microscopy detected the villi interstitial stromal cells with fibroblastic differentiation in CA group.</p><p><strong>Conclusions: </strong>Thus, it is necessary to exclude placenta with obstetrical history, somatic, and congenital pathology of the mother and the child when selecting the placental cell culture. Moreover, choosing a sample the morphological structure of the placenta should be taken into consideration. However, congenital malformations of the fetus, pathology of the mother cultivate mesenchymal stromal cells of placentas is inappropriate and should be taken advantage of the donor cells.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"76-83"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Urethra Reconstruction with Tissue-Engineering Technology]. 用组织工程技术重建尿道。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn771
I A Vasyutin, A V Lyundup, A Z Viranov, D V Butnaru, S L Kuznetsov

Urethral stricture is a disease characterized by a pathological narrowing of the urethra. Treatment for this condition often requires surgery using autologous grafts (urethroplasty). It is common practice to use patient’s own tissue like genital and extragenital skin, tunica vaginalis, buccal mucosa as a source of the graft. Alternative and safer approach is to use tissue-engineered graft created in a laboratory using patient’s autologous cells and biocompatible matrix (scaffold). The article presents the up-to-date achievements in lab-created tissue-engineered graft, describes all components needed to build a tissue-engineered structure of the graft for urethroplasty, and summarizes authors’ thoughts on advantages and disadvantages of various approaches to choose both cellular component and the matrix of future construction. The article reviews clinical studies conducted in the field of tissue engineering of the graft material for urethraplasty.

尿道狭窄是一种以病理性尿道狭窄为特征的疾病。治疗这种情况通常需要手术使用自体移植物(尿道成形术)。通常的做法是使用患者自身的组织,如生殖器和生殖器外皮肤、阴道膜、口腔黏膜作为移植物的来源。另一种更安全的方法是使用患者自身细胞和生物相容性基质(支架)在实验室制造的组织工程移植物。本文介绍了实验室构建组织工程移植物的最新进展,描述了构建用于尿道成形术的组织工程移植物结构所需的所有成分,并总结了作者对选择细胞成分和未来构建基质的各种方法的优缺点的思考。本文综述了组织工程在尿道成形术移植材料方面的临床研究进展。
{"title":"[Urethra Reconstruction with Tissue-Engineering Technology].","authors":"I A Vasyutin,&nbsp;A V Lyundup,&nbsp;A Z Viranov,&nbsp;D V Butnaru,&nbsp;S L Kuznetsov","doi":"10.15690/vramn771","DOIUrl":"https://doi.org/10.15690/vramn771","url":null,"abstract":"<p><p>Urethral stricture is a disease characterized by a pathological narrowing of the urethra. Treatment for this condition often requires surgery using autologous grafts (urethroplasty). It is common practice to use patient’s own tissue like genital and extragenital skin, tunica vaginalis, buccal mucosa as a source of the graft. Alternative and safer approach is to use tissue-engineered graft created in a laboratory using patient’s autologous cells and biocompatible matrix (scaffold). The article presents the up-to-date achievements in lab-created tissue-engineered graft, describes all components needed to build a tissue-engineered structure of the graft for urethroplasty, and summarizes authors’ thoughts on advantages and disadvantages of various approaches to choose both cellular component and the matrix of future construction. The article reviews clinical studies conducted in the field of tissue engineering of the graft material for urethraplasty.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"17-25"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35714883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
[Cardiovascular Effects of Incretin-Based Therapies and Their Therapeutic Potential]. [肠促胰岛素治疗的心血管效应及其治疗潜力]。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn732
I N Tyurenkov, D A Bakulin, D V Kurkin, E V Volotova
Antidiabetic drugs with incretin activity in addition to pronounced hypoglycemic activity cause moderate reduction in blood pressure and fat mass as well as improve the lipid profile in patients with type 2 diabetes mellitus (T2DM). In clinical trials the addition of glucagon-like peptide-1 (GLP-1) analogues to standart T2DM therapy leads to significantly reduce the risk of fatal and nonfatal cardiovascular complications. According to the results of many experimental and clinical studies it was shown that GLP-1 analogs protect endothelium in diabetic patients and protect cardiomyocytes after ischemia-reperfusion lesion. Pleiotropic effects of GLP-1-based therapies are realized due to the presence of GLP-1-receptor in endothelial cells, cardiomyocytes, neurons, monocytes and macrophages, as well as due to the connection of the receptor with the most important intracellular signaling cascades (through activation of protein kinase A and B). Whereby GLP-1-based therapies affect the functional condition as well as processes of regeneration and apoptosis of target cells. This review presents the results of studies the cardiovascular effects of GLP-1-based therapies of diabetes. Described proposed nowadays mechanisms of endothelium protective and cardioprotective action of GLP-1 analogs that associated with the action on endothelial function, vascular wall inflammation (the expression of adhesion molecules and inflammatory cytokines), and apoptosis of endothelial cells and cardiomyocytes.
{"title":"[Cardiovascular Effects of Incretin-Based Therapies and Their Therapeutic Potential].","authors":"I N Tyurenkov,&nbsp;D A Bakulin,&nbsp;D V Kurkin,&nbsp;E V Volotova","doi":"10.15690/vramn732","DOIUrl":"https://doi.org/10.15690/vramn732","url":null,"abstract":"Antidiabetic drugs with incretin activity in addition to pronounced hypoglycemic activity cause moderate reduction in blood pressure and fat mass as well as improve the lipid profile in patients with type 2 diabetes mellitus (T2DM). In clinical trials the addition of glucagon-like peptide-1 (GLP-1) analogues to standart T2DM therapy leads to significantly reduce the risk of fatal and nonfatal cardiovascular complications. According to the results of many experimental and clinical studies it was shown that GLP-1 analogs protect endothelium in diabetic patients and protect cardiomyocytes after ischemia-reperfusion lesion. Pleiotropic effects of GLP-1-based therapies are realized due to the presence of GLP-1-receptor in endothelial cells, cardiomyocytes, neurons, monocytes and macrophages, as well as due to the connection of the receptor with the most important intracellular signaling cascades (through activation of protein kinase A and B). Whereby GLP-1-based therapies affect the functional condition as well as processes of regeneration and apoptosis of target cells. This review presents the results of studies the cardiovascular effects of GLP-1-based therapies of diabetes. Described proposed nowadays mechanisms of endothelium protective and cardioprotective action of GLP-1 analogs that associated with the action on endothelial function, vascular wall inflammation (the expression of adhesion molecules and inflammatory cytokines), and apoptosis of endothelial cells and cardiomyocytes.","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"66-75"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
[Efficacy of Management for Rational Use of Antibiotics in Surgical Departments at a Multi-Disciplinary Hospital: Results of a 7-year Pharmacoepidemiological Research]. 某综合性医院外科合理使用抗生素的管理效果:一项为期7年的药物流行病学研究结果
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn704
A A Korableva, E V Yudina, L E Ziganshina

Background: Irrational medicine use including excessive use and abuse of antibiotics remains a crucial problem for the healthcare systems. In this regard, studies examining approaches to improving the clinical use of medicines are highly important.

Aim: to assess the efficacy rate of management for the rational use of antibiotics in surgical departments of a multi-disciplinary hospital.

Material and methods: The intervention complex combined the research, educational, and methodological activities: local protocols for perioperative antibiotic prophylaxis (PABP) for various surgical departments were developed; local PABP protocols were discussed with the physicians of specialized surgical departments; official order on implementation of PABP was issued; the list of drug prescriptions for registration of the first pre-operative antibiotic dose was changed; audit and feedback processes were introduced as well as consultations of a clinical pharmacologist were implemented. We assessed the efficacy rate of the interventions basing on the changes in consumption of antibiotics (both quantitatively and qualitatively) at surgical departments of a hospital using ATC/DDD methodology. Comparison of the studied outcomes was performed before and after the intervention implementation and between the departments (vascular and abdominal surgery). The consumption of antibacterial agents (ATCJ01) was measured as a number of defined daily doses (DDD) per 100 bed-days (DDD/100 bed-days, indicator recommended by the World Health Organization, WHO) and DDD per 100 treated patients (DDD/100 treated patients).

Results: From 2006 to 2012, a decrease in antibacterial consumption in surgical departments by 188 DDD/100 treated patients was observed. We obtained the opposite results when using an indicator of DDD/100 bed-days (increase by 2.5 DDD/100 bed-days) which could be explained by the dependence on indices of overall hospital work and its changes during the examined period. Observed changes in antibacterial consumption varied in different surgical departments. The most pronounced positive changes were noted in the department of vascular surgery: decrease in total antibacterial consumption by 298 DDD/100 treated patients, decrease in the use of cephalosporins of the III generation from 141 to 38 DDD/100 treated patients. These positive changes were accompanied by the same (low) level of consumption/use of reserve antibiotics. In the department of abdominal surgery, there was no decrease in total antibiotic consumption, as well as in consumption of broad-spectrum cephalosporins of the III generation and fluoroquinolones, and we observed an increase in the use of reserve antibiotics (carbapenems) during the study period. Positive changes in antibiotic consumption were associated with the positive attitude of the manager/head of the department towards interventions: we observed the mos

背景:包括过度使用和滥用抗生素在内的不合理用药仍然是卫生保健系统面临的一个关键问题。在这方面,研究改善药物临床使用的方法非常重要。目的:评价某综合性医院外科抗菌药物合理使用管理的有效率。材料和方法:干预综合了研究、教育和方法活动:制定了各个外科部门围手术期抗生素预防(PABP)的地方协议;与专科外科医师讨论当地PABP方案;发布了关于执行PABP的正式命令;更改术前第一次抗生素剂量注册用药处方清单;审计和反馈过程被引入,以及临床药理学家的咨询被实施。我们采用ATC/DDD方法,根据医院外科抗生素使用量的变化(定量和定性)评估干预措施的有效率。比较干预实施前后及科室间(血管外科和腹部外科)的研究结果。抗菌药物(ATCJ01)的消耗量以每100个住院日的确定日剂量(DDD/100个住院日,世界卫生组织推荐的指标)和每100名治疗患者的DDD (DDD/100名治疗患者)来测量。结果:2006 - 2012年外科抗菌药物用量下降188 DDD/100例。当使用DDD/100住院日指标时,我们得到了相反的结果(增加2.5 DDD/100住院日),这可以解释为对医院整体工作指标的依赖及其在研究期间的变化。观察到的抗菌药物用量变化在不同的外科科室有所不同。最明显的积极变化发生在血管外科:抗菌药物总用量减少298 DDD/100名治疗患者,第三代头孢菌素的使用从141 DDD/100名治疗患者减少到38 DDD/100名。这些积极的变化伴随着储备抗生素的消费/使用水平相同(低)。在腹部外科,抗生素的总使用量没有减少,三代广谱头孢菌素和氟喹诺酮类药物的使用量也没有减少,我们观察到在研究期间,储备抗生素(碳青霉烯类)的使用有所增加。抗生素用量的积极变化与部门经理/主管对干预措施的积极态度有关:我们观察到,在公布围手术期抗菌预防行政命令后,抗生素用量的下降最为明显。结论:科学、教育和方法相结合的干预措施对提高抗生素的应用是有效的。该研究结果为使用DDD/100名接受治疗患者的测量方法分析药物消耗提供了依据,此外还使用了世卫组织推荐的DDD/100个床位日指标,该指标取决于医院的总体表现。
{"title":"[Efficacy of Management for Rational Use of Antibiotics in Surgical Departments at a Multi-Disciplinary Hospital: Results of a 7-year Pharmacoepidemiological Research].","authors":"A A Korableva,&nbsp;E V Yudina,&nbsp;L E Ziganshina","doi":"10.15690/vramn704","DOIUrl":"https://doi.org/10.15690/vramn704","url":null,"abstract":"<p><strong>Background: </strong>Irrational medicine use including excessive use and abuse of antibiotics remains a crucial problem for the healthcare systems. In this regard, studies examining approaches to improving the clinical use of medicines are highly important.</p><p><strong>Aim: </strong>to assess the efficacy rate of management for the rational use of antibiotics in surgical departments of a multi-disciplinary hospital.</p><p><strong>Material and methods: </strong>The intervention complex combined the research, educational, and methodological activities: local protocols for perioperative antibiotic prophylaxis (PABP) for various surgical departments were developed; local PABP protocols were discussed with the physicians of specialized surgical departments; official order on implementation of PABP was issued; the list of drug prescriptions for registration of the first pre-operative antibiotic dose was changed; audit and feedback processes were introduced as well as consultations of a clinical pharmacologist were implemented. We assessed the efficacy rate of the interventions basing on the changes in consumption of antibiotics (both quantitatively and qualitatively) at surgical departments of a hospital using ATC/DDD methodology. Comparison of the studied outcomes was performed before and after the intervention implementation and between the departments (vascular and abdominal surgery). The consumption of antibacterial agents (ATCJ01) was measured as a number of defined daily doses (DDD) per 100 bed-days (DDD/100 bed-days, indicator recommended by the World Health Organization, WHO) and DDD per 100 treated patients (DDD/100 treated patients).</p><p><strong>Results: </strong>From 2006 to 2012, a decrease in antibacterial consumption in surgical departments by 188 DDD/100 treated patients was observed. We obtained the opposite results when using an indicator of DDD/100 bed-days (increase by 2.5 DDD/100 bed-days) which could be explained by the dependence on indices of overall hospital work and its changes during the examined period. Observed changes in antibacterial consumption varied in different surgical departments. The most pronounced positive changes were noted in the department of vascular surgery: decrease in total antibacterial consumption by 298 DDD/100 treated patients, decrease in the use of cephalosporins of the III generation from 141 to 38 DDD/100 treated patients. These positive changes were accompanied by the same (low) level of consumption/use of reserve antibiotics. In the department of abdominal surgery, there was no decrease in total antibiotic consumption, as well as in consumption of broad-spectrum cephalosporins of the III generation and fluoroquinolones, and we observed an increase in the use of reserve antibiotics (carbapenems) during the study period. Positive changes in antibiotic consumption were associated with the positive attitude of the manager/head of the department towards interventions: we observed the mos","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"26-32"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35714884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body]. 对氧磷酶:人体抗氧化防御的通用因子。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn764
E I Borovkova, N V Antipova, T V Komeenko, M I Shakhparonov, I M Borovkov

The paraoxonase (PON) gene family includes three members: PON1, PON2, and PON3 aligned in tandem on chromosome 7 in humans. All PON proteins share considerable structural homology and have the capacity to protect cells from oxidative stress; therefore, they have been implicated in the pathogenesis of several inflammatory diseases, particularly atherosclerosis. Increased production of reactive oxygen species as a result of decreased activities of mitochondrial electron transport chain complexes plays a role in the development of many inflammatory diseases, including atherosclerosis. PON1 and PON3 proteins can be detected in plasma and reside in the high-density lipoprotein fraction and protect against oxidative stress by hydrolyzing certain oxidized lipids in lipoproteins, macrophages, and atherosclerotic lesions. Paraoxonase 2 (PON2) possesses antiatherogenic properties and is associated with lower ROS levels. PON2 is involved in the antioxidative and anti-inflammatory response in intestinal epithelial cells. In contrast to PON1 and PON3, PON2 is cell-associated and is not found in plasma. It is widely expressed in a variety of tissues, including the kidney, and protects against cellular oxidative stress. Overexpression of PON2 reduces oxidative status, prevents apoptosis in vascular endothelial cells, and inhibits cell-mediated low density lipoprotein oxidation. PON2 also inhibits the development of atherosclerosis, via mechanisms involving the reduction of oxidative stress. In this review we explore the physiological roles of PON in disease development and modulation of PONs by infective (bacterial, viral) agents.

对氧磷酶(PON)基因家族包括三个成员:PON1、PON2和PON3,它们在人类的7号染色体上串联排列。所有PON蛋白具有相当大的结构同源性,并具有保护细胞免受氧化应激的能力;因此,它们与几种炎症性疾病,特别是动脉粥样硬化的发病机制有关。由于线粒体电子传递链复合物活性降低,活性氧的产生增加,在包括动脉粥样硬化在内的许多炎症性疾病的发展中起作用。PON1和PON3蛋白可以在血浆中检测到,存在于高密度脂蛋白中,并通过水解脂蛋白、巨噬细胞和动脉粥样硬化病变中的某些氧化脂质来防止氧化应激。对氧磷酶2 (PON2)具有抗动脉粥样硬化特性,并与较低的ROS水平相关。PON2参与肠上皮细胞的抗氧化和抗炎反应。与PON1和PON3不同,PON2与细胞相关,不存在于血浆中。它在多种组织中广泛表达,包括肾脏,并保护细胞免受氧化应激。PON2过表达可降低氧化状态,防止血管内皮细胞凋亡,抑制细胞介导的低密度脂蛋白氧化。PON2还通过减少氧化应激的机制抑制动脉粥样硬化的发展。在这篇综述中,我们探讨了PON在疾病发展中的生理作用以及感染(细菌、病毒)因子对PON的调节。
{"title":"[Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body].","authors":"E I Borovkova,&nbsp;N V Antipova,&nbsp;T V Komeenko,&nbsp;M I Shakhparonov,&nbsp;I M Borovkov","doi":"10.15690/vramn764","DOIUrl":"https://doi.org/10.15690/vramn764","url":null,"abstract":"<p><p>The paraoxonase (PON) gene family includes three members: PON1, PON2, and PON3 aligned in tandem on chromosome 7 in humans. All PON proteins share considerable structural homology and have the capacity to protect cells from oxidative stress; therefore, they have been implicated in the pathogenesis of several inflammatory diseases, particularly atherosclerosis. Increased production of reactive oxygen species as a result of decreased activities of mitochondrial electron transport chain complexes plays a role in the development of many inflammatory diseases, including atherosclerosis. PON1 and PON3 proteins can be detected in plasma and reside in the high-density lipoprotein fraction and protect against oxidative stress by hydrolyzing certain oxidized lipids in lipoproteins, macrophages, and atherosclerotic lesions. Paraoxonase 2 (PON2) possesses antiatherogenic properties and is associated with lower ROS levels. PON2 is involved in the antioxidative and anti-inflammatory response in intestinal epithelial cells. In contrast to PON1 and PON3, PON2 is cell-associated and is not found in plasma. It is widely expressed in a variety of tissues, including the kidney, and protects against cellular oxidative stress. Overexpression of PON2 reduces oxidative status, prevents apoptosis in vascular endothelial cells, and inhibits cell-mediated low density lipoprotein oxidation. PON2 also inhibits the development of atherosclerosis, via mechanisms involving the reduction of oxidative stress. In this review we explore the physiological roles of PON in disease development and modulation of PONs by infective (bacterial, viral) agents.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35714881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
[The Role of Reactive Oxygen Species in the Pathogenesis of Adipocyte Dysfunction in Metabolic Syndrome. Prospects of Pharmacological Correction]. 活性氧在代谢综合征脂肪细胞功能障碍发病机制中的作用。药物矫正的前景[j]。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn798
E S Prokudina, L N Maslov, V V Ivanov, I D Bespalova, D S Pismennyi, N S Voronkov

It is established that oxidative stress induces insulin resistance of adipocytes, increases secretion leptin, IL-6, TNF-α by adipocytes. Adiponectin secretion by adipocytes is reduced after the action of reactive oxygen species. Metabolic syndrome contributes to oxidative stress in adipose tissue, on the one hand due to the activation of production of reactive oxygen species by adipocyte NADPH-oxidase, and on the other hand by reducing the antioxidant defense adipocytes. It is found that obesity itself can induce oxidative stress. Chronic stress, glucocorticoids, mineralocorticoids, angiotensin-II, TNF-α play an important role in the pathogenesis of oxidative stress of adipocytes. Metformin remains the cure for the treatment of insulin resistance. The positive results in the treatment of metabolic syndrome by losartan were obtained. Antioxidants and flavonoids exhibit a positive impact on the course of the experimental metabolic syndrome.

氧化应激诱导脂肪细胞胰岛素抵抗,增加脂肪细胞分泌瘦素、IL-6、TNF-α。在活性氧的作用下,脂肪细胞分泌的脂联素减少。代谢综合征导致脂肪组织氧化应激,一方面是由于脂肪细胞nadph氧化酶激活活性氧的产生,另一方面是由于脂肪细胞的抗氧化防御能力降低。研究发现,肥胖本身可以诱发氧化应激。慢性应激、糖皮质激素、矿物皮质激素、血管紧张素- ii、TNF-α在脂肪细胞氧化应激的发病机制中起重要作用。二甲双胍仍然是治疗胰岛素抵抗的良方。氯沙坦治疗代谢综合征的阳性结果。抗氧化剂和类黄酮对实验性代谢综合征的病程有积极影响。
{"title":"[The Role of Reactive Oxygen Species in the Pathogenesis of Adipocyte Dysfunction in Metabolic Syndrome. Prospects of Pharmacological Correction].","authors":"E S Prokudina,&nbsp;L N Maslov,&nbsp;V V Ivanov,&nbsp;I D Bespalova,&nbsp;D S Pismennyi,&nbsp;N S Voronkov","doi":"10.15690/vramn798","DOIUrl":"https://doi.org/10.15690/vramn798","url":null,"abstract":"<p><p>It is established that oxidative stress induces insulin resistance of adipocytes, increases secretion leptin, IL-6, TNF-α by adipocytes. Adiponectin secretion by adipocytes is reduced after the action of reactive oxygen species. Metabolic syndrome contributes to oxidative stress in adipose tissue, on the one hand due to the activation of production of reactive oxygen species by adipocyte NADPH-oxidase, and on the other hand by reducing the antioxidant defense adipocytes. It is found that obesity itself can induce oxidative stress. Chronic stress, glucocorticoids, mineralocorticoids, angiotensin-II, TNF-α play an important role in the pathogenesis of oxidative stress of adipocytes. Metformin remains the cure for the treatment of insulin resistance. The positive results in the treatment of metabolic syndrome by losartan were obtained. Antioxidants and flavonoids exhibit a positive impact on the course of the experimental metabolic syndrome.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"11-6"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35714882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
[Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data]. 大麻素受体配体治疗代谢综合征和动脉粥样硬化的前景:实验和临床数据分析。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.15690/vramn779
L N Maslov, R S Karpov

An antagonist of central cannabinoid CB1 receptors rimonabant causes weight loss in patients with obesity and metabolic syndrome, improves blood lipid parameters, increases the adiponectin level, decreases the rate of glucose and glycosylated hemoglobin in patients with diabetes mellitustype-2. However, rimonabant adverse effects include depression, anxiety, nausea, and dizziness which are apparently due to the blockade of central CB1 receptors. In mice with a high-calorie diet, we defined that the blockade of peripheral CB1 receptors prevents obesity, steatosis of the liver, improves lipid and carbohydrate metabolism. Experimental studies suggest that peripheral CB2 receptor agonists have antiatherogenic effect. To validate the expediency of clinical research of CB2 receptor agonists in patients with atherosclerosis the comparative analysis of antiatherogenic properties of cannabinoids should be performed. In addition, experiments are needed on the combination use of cannabinoids with well-known antiatherogenic agents, such as statins.

中枢大麻素CB1受体拮抗剂利莫那班可使肥胖和代谢综合征患者体重减轻,改善血脂参数,增加脂联素水平,降低糖尿病2型患者的葡萄糖和糖化血红蛋白率。然而,利莫那班的副作用包括抑郁、焦虑、恶心和头晕,这显然是由于中枢CB1受体的阻断。在高热量饮食的小鼠中,我们确定外周CB1受体的阻断可以防止肥胖,肝脏脂肪变性,改善脂质和碳水化合物代谢。实验研究表明外周CB2受体激动剂具有抗动脉粥样硬化作用。为了验证CB2受体激动剂在动脉粥样硬化患者中临床研究的便利性,需要对大麻素的抗动脉粥样硬化特性进行比较分析。此外,大麻素与著名的抗动脉粥样硬化药物(如他汀类药物)联合使用的实验也需要进行。
{"title":"[Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data].","authors":"L N Maslov,&nbsp;R S Karpov","doi":"10.15690/vramn779","DOIUrl":"https://doi.org/10.15690/vramn779","url":null,"abstract":"<p><p>An antagonist of central cannabinoid CB1 receptors rimonabant causes weight loss in patients with obesity and metabolic syndrome, improves blood lipid parameters, increases the adiponectin level, decreases the rate of glucose and glycosylated hemoglobin in patients with diabetes mellitus\u0000type-2. However, rimonabant adverse effects include depression, anxiety, nausea, and dizziness which are apparently due to the blockade of central CB1 receptors. In mice with a high-calorie diet, we defined that the blockade of peripheral CB1 receptors prevents obesity, steatosis of the liver, improves lipid and carbohydrate metabolism. Experimental studies suggest that peripheral CB2 receptor agonists have antiatherogenic effect. To validate the expediency of clinical research of CB2 receptor agonists in patients with atherosclerosis the comparative analysis of antiatherogenic properties of cannabinoids should be performed. In addition, experiments are needed on the combination use of cannabinoids with well-known antiatherogenic agents, such as statins.</p>","PeriodicalId":39355,"journal":{"name":"Vestnik Rossiiskoi Akademii Meditsinskikh Nauk","volume":"72 1","pages":"59-65"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35715716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
期刊
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1